Biohaven Stock Falls 4.9% as Raymond James Cuts Target to $30 After Opakalim Deal
Biohaven Ltd. shares fell 4.9% on Thursday after Raymond James cut its price target by 40%. The stock closed at $16.12.
Investor Dashboard
Iwona Majkowska is a financial markets journalist at TS2.tech. She covers stocks, artificial intelligence and technology, with a focus on the stories moving U.S. and global markets. Before turning to financial journalism, she worked in equity research and financial analysis. She is a graduate of the Warsaw School of Economics. Follow Iwona Majkowska on Google News.
